Galera Therapeutics, Inc. - Common Stock, $0.001 par value per share (GRTX) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2019 to Q3 2024

Type / Class
Equity / Common Stock, $0.001 par value per share
Symbol
GRTX on OTC
Shares outstanding
75,462,362
Price per share
$0.05
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Galera Therapeutics, Inc. - Common Stock, $0.001 par value per share (GRTX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Ikarian Capital, LLC 10% $376,934 7,538,690 Ikarian Capital, LLC 31 Dec 2024

Institutional Holders of Galera Therapeutics, Inc. - Common Stock, $0.001 par value per share (GRTX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2024 Q3 0 $0 -$7,129 $0.05 0
2024 Q2 52,113 $7,129 -$1,362,683 $0.14 1
2024 Q1 9,781,540 $1,369,942 -$464,149 $0.14 36
2023 Q4 12,938,655 $1,880,595 +$590,763 $0.15 35
2023 Q3 8,715,871 $1,524,972 -$27,528,247 $0.18 37
2023 Q2 18,499,043 $57,712,293 -$447,116 $3.12 54
2023 Q1 18,664,781 $47,781,720 +$17,178,137 $2.56 38
2022 Q4 11,979,852 $17,848,987 +$2,357,662 $1.49 30
2022 Q3 10,382,905 $18,065,000 -$188,983 $1.74 26
2022 Q2 10,506,972 $13,661,000 -$953,786 $1.30 31
2022 Q1 11,246,268 $26,731,000 -$823,530 $2.38 43
2021 Q4 10,971,284 $50,328,000 -$76,569,488 $4.59 40
2021 Q3 19,973,159 $161,783,000 -$4,919,540 $8.10 39
2021 Q2 20,492,197 $201,439,000 +$8,954,323 $9.83 45
2021 Q1 19,103,999 $168,495,000 -$2,896,508 $8.82 54
2020 Q4 19,276,556 $197,203,000 +$5,699,352 $10.23 51
2020 Q3 18,815,262 $170,089,000 +$965,546 $9.04 42
2020 Q2 18,721,615 $133,673,000 +$13,035,881 $7.14 40
2020 Q1 16,811,414 $159,710,000 -$1,360,664 $9.50 29
2019 Q4 16,993,214 $223,631,000 +$223,301,815 $13.16 30